In patients possessing both anti-Ro52 and anti-Jo-1 antibodies, we observed increased prevalence/severity of ILD, Raynaud’s phenomenon, and xerophthalmia as well as xerostomia. This evidence concerns the gene TRIM21 and Keratoconjunctivitis sicca.